Klinik Altona
Prof. Dr. med. Martin W. Bergmann
Chefarzt
Innere Medizin, Kardiologie
Sprechstunden
Sehen Sie sich meine Sprechstunden an und vereinbaren Sie einen Termin.
Weiterbildungsbefugnisse
- Innere Medizin und/oder Allgemeinmedizin / Basisweiterbildung / 36 Monate / LÄK Hamburg / WBO 05 /
- Innere Medizin und/oder Allgemeinmedizin / Kardiologie / 36 Monate / LÄK Hamburg / WBO 05 /
- Zusatzweiterbildung / Intensivmedizin / 12 Monate / LÄK Hamburg / WBO 05 /
Kurzvita
Höhepunkte der beruflichen Laufbahn
- 2005 Oberarzt, Herzkatheter Franz-Volhard-Klinik, Charité Campus Buch, Berlin
- 2008 stellvertretender Leiter & Leitender Oberarzt Abt. Kardiologie, Asklepios Klinik St. Georg
- 2014 Gesellschafter Cardiologicum Hamburg
- 2014 Leiter des Katheterlabors Cardiologicum / Asklepios Klinik Wandsbek
- 2016 Konsiliararzt Abt. Kardiologie, Asklepios Klinik St. Georg
- 2019 Chefarzt Abt. Innere Medizin Kardiologie/Pneumologie Asklepios Klinik Wandsbek
- 2020 Chefarzt Kardiologie, Pneumologie & internistische Intensivmedizin, Asklepios Klinik Altona
Universitäre Ausbildung
- 1993 Studium der Humanmedizin Christian-Albrechts-Universität zu Kiel
- 1996 AiP/wissenschaftlicher Assistent, I. Medizinische Universitätsklinik Christian-Albrechts-Universität zu Kiel
- 1998 Ausbildungsstipendium Deutsche Forschungsgemeinschaft
- 1998 DFG Forschungsstipendium
- 2004 wissenschaftlicher Assistent, Franz-Volhard-Klinik, Charité Campus Berlin-Buch, Prof. Dr. Rainer Dietz, Prof. Dr. Friedrich Luft & Prof. D. Ganten
- 2005 Helmholtz-Stipendiat
Mitgliedschaften in medizinischen Fachgesellschaften
- Arbeitsgruppe Interventionelle Kardiologie der DGK
- Deutsche Gesellschaft für Kardiologie
- European Association of Percutaneous Cardiac Interventions (EAPCI)
- Faculty EuroPCR Course
- Faculty Transcatheter Cardiovascular Therapeutics (TCT)
- Klinische Kommission der Deutschen Gesellschaft für Kardiologie
Weitere Qualifikation
- Fellow der European Society of Cardiology
- Zusatzbezeichnung spezielle, internistische Intensivmedizin
- Zusatzqualifikation Herzinsuffizienz
- Zusatzqualifikation interventionelle Kardiologie
Forschung & Lehre
Wissenschaftliche Interessen
- Grundlagenforschung Herzinsuffizienz und kardiale Regeneration
- Grundlagenforschung molekulare Signaltransduktion
- Interventionelle Kardiologie: PCI & invasive Bildgebung
- Strukturelle Herzerkrankungen: TAVI, LAA-Verschluss, inter-atriale Shunts
Wissenschaftliche Auszeichnungen und Preise
- 2007 Winterstein Preis der Deutschen Herzstiftung
- 2013 Forschungspreis der Asklepios Kliniken
- European Socienty of Cardiology
Weitere Publikationen
- Analysis of Immunoglobulins in Sarcoidosis
- Evidence for involvement of NF-B in the transcriptional control of COX-2 gene expression by IL-1
- B degradation and nuclear factor-B DNA binding are insufficient for interleukin-1 and tumor necrosis factor- induced B-dependent transcription
- Effect of dexamethasone on IL-1 -induced NF-B and B-dependent transcription in epithelial cells
- Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation
- Repression of COX-2 and PGE2 Release by Dexamethasone Occurs by Transcriptional and Post-transcriptional Mechanisms Involving Loss of Polyadenylated mRNA
- Molecular Regulation of Granulocyte-Macrophage Colony-Stimulating Factor in Human Lung Epithelial Cells by Interleukin (IL)-1beta, IL-4, and IL-13 Involves Both Transcriptional and Post-Transcriptional Mechanisms
- Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action
- Adenosine 3',5'-Cyclic Monophosphate (cAMP)-Dependent Inhibition of IL- 5 from Human T Lymphocytes Is Not Mediated by the cAMP-Dependent Protein Kinase A
- Effect of NF- kappa B Inhibition on TNF- alpha -induced Apoptosis and Downstream Pathways in Cardiomyocytes
- GM-CSF expression in pulmonary epithelial cells is regulated negatively by posttranscriptional mechanisms
- In Cardiomyocyte Hypoxia, IGF-I-Induced Antiapoptotic Signaling Requires PI3-kinase- Dependent and MAPK-Dependent Activation of the Transcription Factor CREB
- Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone
- IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase
- . Dexamethason inhibits T-cell GM-CSF release independent of NF-B. Role of post-transcriptional mechanisms
- Glucocorticoid inhibition of GM-CSF from T cells is independent of control by NF-{kappa}B and CLE0
- Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: Activation of CREB downstream of GSK3
- Statins inhibit cardiomyocyte apoptosis by inhibition of GSK3: stabilization of -catenin
- Requirement of NF-B in angiotensin II- and isoproterenol- induced cardiac hypertrophy in vivo
- -catenin downregulation is required for adaptive cardiac remodeling
- Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation
- MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload
- NF-{kappa}B activation is required for adaptive cardiac hypertrophy
- Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: Design and rationale of the abciximab intracoronary versus intravenously drug application in st-elevation myocardial infarction (aida stemi) trial
- Chronic, low-dose epoetin- following PCI attenuates left ventricular remodeling in patients with ischemic cardiomyopathy
- Krueppel-like factor 15 regulates Wnt/β-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart
- Delivery of a bioresorbable vascular scaffold to complex lesions
- New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN device in patients not taking warfarin
- Percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock: Results of the impella-euroshock-registry
- The four and a half lim-domain 2 controls early cardiac cell commitment and expansion via regulating beta-catenin-dependent transcription
- Cardiac tamponade due to coronary perforation during percutaneous interventions successfully treated with microspheres
- Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques
- Percutaneous left atrial appendage closure in patients with left atrial appendage thrombus
- Results of the ALSTER BP Real World Registry on renal denervation employing the SYMPLICITY system
- Risk factors for clinical events at 1-year follow-up after drug-eluting stent implantation: results from the prospective multicenter German DES.DE registry
- EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology
- Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data
- Multimodality Intra-Arterial Imaging Assessment of the Vascular Trauma Induced by Balloon-Based and Nonballoon-Based Renal Denervation Systems
- Percutaneous left atrial appendage closure in patients with left atrial appendage thrombus
- Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study
- Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition
- Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry
- Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
- Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
- Safety and efficacy of lesion preparation with the AngioSculpt Scoring Balloon in left main interventions: the ALSTER Left Main registry
- Clinical Cases in LAA Occlusion
- Improved Algorithm for Ostium Size Assessment in Watchman Left Atrial Appendage Occlusion Using Three-Dimensional Echocardiography
- Investigators E. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial
- Oral anticoagulation and platelet inhibition after atrial appendage occlusion
- The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial
- Trends Cardiovasc Med
- European registry data on LAA closure: advancing the field of interventional stroke prevention
- European registry data on LAA closure: advancing the field of interventional stroke prevention
- Incidence of pericardial effusion after left atrial appendage closure: The impact of underlying heart rhythm-Data from the EWOLUTION study
- Incidence of pericardial effusion after left atrial appendage closure: The impact of underlying heart rhythm-Data from the EWOLUTION study
- Optical coherence tomography-guided versus angiography-guided implantation of everolimus-eluting bioresorbable vascular scaffolds: Comparison of coverage, apposition and clinical outcome
- Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study
- Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study
- Three-months optical coherence tomography analysis of a biodegradable polymer, sirolimus-eluting stent
- Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology
- Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction
- Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock
- Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)
- The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction
- Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure
- Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN
- The atrial flow regulator: current overview on technique and first experience
- Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN
- Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation
- One-year results of the first-in-man study investigating the Atrial-Flow-Regulator for left-atrial shunting in symptomatic heart failure patients: the PRELIEVE study
Aktuelle Lehrtätigkeit
- Lehrbefugnis für das Fach Innere Medizin Charité
- Lehrbefugnis für das Fach Innere Medizin UKE
- Professor §117 Hamburger Hochschulgesetz